Compile Data Set for Download or QSAR
Report error Found 132 Enz. Inhib. hit(s) with all data for entry = 50013931
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136037(1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532)
Affinity DataIC50: 7nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136037(1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532)
Affinity DataIC50: 7nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136043(4-(4-Butoxy-phenyl)-pyrimidine | CHEMBL151974)
Affinity DataIC50: 46nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136043(4-(4-Butoxy-phenyl)-pyrimidine | CHEMBL151974)
Affinity DataIC50: 46nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136043(4-(4-Butoxy-phenyl)-pyrimidine | CHEMBL151974)
Affinity DataIC50: 46nMAssay Description:Concentration required to inhibit cytochrome P450 2C9.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136059(5-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL151170)
Affinity DataIC50: 46nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136047(2-(4-Butoxy-phenyl)-pyrazine | CHEMBL150146)
Affinity DataIC50: 46nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136038(1-(4-Butoxy-phenyl)-1H-[1,2,4]triazole | CHEMBL345...)
Affinity DataIC50: 68nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136056(1-(4-Butoxy-phenyl)-5-methyl-1H-imidazole | CHEMBL...)
Affinity DataIC50: 88nMAssay Description:Concentration required to inhibit cytochrome P450 2C9.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136037(1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532)
Affinity DataIC50: 96nMAssay Description:Concentration required to inhibit cytochrome P450 2C9.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136056(1-(4-Butoxy-phenyl)-5-methyl-1H-imidazole | CHEMBL...)
Affinity DataIC50: 116nMAssay Description:Concentration required to inhibit cytochrome P450 3A4.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136035(5-(2-Butoxy-phenyl)-isoxazole | CHEMBL150799)
Affinity DataIC50: 120nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136056(1-(4-Butoxy-phenyl)-5-methyl-1H-imidazole | CHEMBL...)
Affinity DataIC50: 120nMAssay Description:Concentration required to inhibit cytochrome P450 2D6.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136054(N-(4-butoxyphenyl)-N'-hydroxyimidoformamide | CHEM...)
Affinity DataIC50: 270nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50106737(N-(4-butyl-2-methylphenyl)-N'-hydroxyimidoformamid...)
Affinity DataIC50: 272nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136038(1-(4-Butoxy-phenyl)-1H-[1,2,4]triazole | CHEMBL345...)
Affinity DataIC50: 283nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136048(5-(4-Butoxy-phenyl)-2H-tetrazole | CHEMBL150278)
Affinity DataIC50: 316nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136037(1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532)
Affinity DataIC50: 348nMAssay Description:Concentration required to inhibit cytochrome P450 3A4.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136061(1-(4-Butoxy-phenyl)-4-methyl-1H-imidazole | CHEMBL...)
Affinity DataIC50: 360nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136061(1-(4-Butoxy-phenyl)-4-methyl-1H-imidazole | CHEMBL...)
Affinity DataIC50: 386nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136034(4-(4-Butoxy-phenyl)-pyridine | CHEMBL151280)
Affinity DataIC50: 398nMAssay Description:Concentration required to inhibit cytochrome P450 2D6.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136037(1-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL112532)
Affinity DataIC50: 460nMAssay Description:Concentration required to inhibit cytochrome P450 2D6.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50106737(N-(4-butyl-2-methylphenyl)-N'-hydroxyimidoformamid...)
Affinity DataIC50: 461nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136042(5-(4-Butoxy-phenyl)-4-methyl-isoxazole | CHEMBL151...)
Affinity DataIC50: 480nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136040(2-(4-Butoxy-phenyl)-pyridine | CHEMBL150653)
Affinity DataIC50: 487nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136043(4-(4-Butoxy-phenyl)-pyrimidine | CHEMBL151974)
Affinity DataIC50: 500nMAssay Description:Concentration required to inhibit cytochrome P450 2D6.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136036(5-(3-Butoxy-phenyl)-isoxazole | CHEMBL151449)
Affinity DataIC50: 570nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136049(1-(4-Butoxy-phenyl)-2-methyl-1H-imidazole | CHEMBL...)
Affinity DataIC50: 770nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136059(5-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL151170)
Affinity DataIC50: 883nMAssay Description:Concentration required to inhibit cytochrome P450 3A4.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136041(2-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL150999)
Affinity DataIC50: 940nMAssay Description:Concentration required to inhibit cytochrome P450 2D6.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136052(5-(4-Butoxy-phenyl)-oxazole | CHEMBL358216)
Affinity DataIC50: 1.01E+3nMAssay Description:Concentration required to inhibit cytochrome P450 2D6.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136059(5-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL151170)
Affinity DataIC50: 1.10E+3nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136045(5-(4-Butoxy-phenyl)-isothiazole | CHEMBL151354)
Affinity DataIC50: 1.26E+3nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136036(5-(3-Butoxy-phenyl)-isoxazole | CHEMBL151449)
Affinity DataIC50: 1.63E+3nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136062(5-(4-Butoxy-phenyl)-1-methyl-1H-pyrazole | CHEMBL1...)
Affinity DataIC50: 1.97E+3nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136051(3-(4-Butoxy-phenyl)-isoxazole | CHEMBL433737)
Affinity DataIC50: 2.55E+3nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136038(1-(4-Butoxy-phenyl)-1H-[1,2,4]triazole | CHEMBL345...)
Affinity DataIC50: 2.80E+3nMAssay Description:Concentration required to inhibit cytochrome P450 2C9.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136039(5-(4-Butoxy-phenyl)-4-methyl-1H-pyrazole | CHEMBL4...)
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136053(5-(4-Butoxy-phenyl)-1H-pyrazole | CHEMBL149750)
Affinity DataIC50: 3.16E+3nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136058(5-(4-Butoxy-phenyl)-isoxazole | CHEMBL150681)
Affinity DataIC50: 3.23E+3nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136040(2-(4-Butoxy-phenyl)-pyridine | CHEMBL150653)
Affinity DataIC50: 3.57E+3nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136051(3-(4-Butoxy-phenyl)-isoxazole | CHEMBL433737)
Affinity DataIC50: 3.68E+3nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50106737(N-(4-butyl-2-methylphenyl)-N'-hydroxyimidoformamid...)
Affinity DataIC50: 4.17E+3nMAssay Description:Concentration required to inhibit cytochrome P450 2C9.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136055(5-(4-Butoxy-phenyl)-3-methyl-isoxazole | CHEMBL422...)
Affinity DataIC50: 5.22E+3nMAssay Description:Concentration required to inhibit cytochrome P450 2C9.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136058(5-(4-Butoxy-phenyl)-isoxazole | CHEMBL150681)
Affinity DataIC50: 5.51E+3nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136053(5-(4-Butoxy-phenyl)-1H-pyrazole | CHEMBL149750)
Affinity DataIC50: 5.65E+3nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136060(3-(4-Butoxy-phenyl)-1H-pyrrole | CHEMBL359116)
Affinity DataIC50: 5.85E+3nMAssay Description:Concentration required to inhibit cytochrome P450 1A2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136059(5-(4-Butoxy-phenyl)-1H-imidazole | CHEMBL151170)
Affinity DataIC50: 6.00E+3nMAssay Description:Concentration required to inhibit cytochrome P450 2D6.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136055(5-(4-Butoxy-phenyl)-3-methyl-isoxazole | CHEMBL422...)
Affinity DataIC50: 6.07E+3nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50136060(3-(4-Butoxy-phenyl)-1H-pyrrole | CHEMBL359116)
Affinity DataIC50: 6.08E+3nMAssay Description:Inhibition of cytochrome P450 CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 132 total ) | Next | Last >>
Jump to: